WHOOP’s $575 million raise signals the global interest in health wearables 

WHOOP has raised $575m at a $10.1bn valuation, signalling its evolution from fitness wearable to personalised health platform and growing investor confidence in preventative digital health.

Interested in learning more about investment for healthtech innovation? Sign up to the HIN Investment Update.

US-based wearable technology company WHOOP has raised $575 million in a major Series G funding round, valuing the business at $10.1 billion, almost triple its last publicly reported valuation in 2021. The raise will support the company to advance its global expansion and long-term vision for personalised health. The round was led by Collaborative Fund and includes global participation from 2PointZero Group, Qatar Investment Authority (QIA), Mubadala Investment Company, Abbott, Mayo Clinic, Macquarie Capital (entities administered by Macquarie Capital), Glade Brook, B-Flexion, IVP, Foundry, Accomplice, Affinity Partners, Promus Ventures, and Bullhound Capital.  

Best known for its screenless, subscription-based wearable, WHOOP has built a loyal following amongst elite athletes and health-conscious consumers. Its roster of celebrity investors includes Cristiano Ronaldo, LeBron James, Rory McIlroy and Niall Horan, helping propel the brand into mainstream awareness.  

This sizeable raise indicates WHOOP’s ambitions beyond performance optimisation and positions it firmly on a path toward a future public listing. 

From fitness gadget to health platform 

WHOOP is actively repositioning itself as a comprehensive personal health platform, rather than a fitness accessory. Strategic investments from healthcare heavyweights such as Abbott and the Mayo Clinic in this funding round reinforce this shift, signalling an intent to bridge the gap between consumer wearables and medical-grade health tools. 

This strategic direction began to take shape in May 2025, when WHOOP launched its first FDA-cleared medical-grade features in the US. These included an electrocardiogram (ECG), blood pressure insights, and a metric called Healthspan, which is designed to estimate the “pace of ageing.”  

Integrating wearable data with diagnostics 

Later in 2025, WHOOP extended its platform further with the launch of an Advanced Labs service. This offering combines continuous wearable data with blood testing, enabling deeper insights into biomarkers like cholesterol, inflammation, and metabolic health. The goal is to create a continuous feedback loop to link insights from wearable data and lab results, delivered seamlessly through the WHOOP app. 

These new features have the potential to give users more timely, actionable insights into long-term health risks, rather than just short-term performance metrics. This approach reflects a broader trend in digital health: moving from episodic testing toward continuous, preventative care.  

With the increase in consumer wearables, like WHOOP, looking to shift into more clinically relevant areas, health and care systems could benefit from this baseline data. By supporting the use and sharing of clinically relevant data collected by patients, the NHS could target resources without being overwhelmed by demand from the ‘worried well’. This was reflected by a the Wearables for Emergency Departments Healthcare Challenge, which was delivered by DigitalHealth.London recently, and revealed the potential benefit of real-time continuous monitoring.  

IPO on the Horizon? 

With its expanded clinical ambitions, deep-pocketed backers, and fast-growing valuation, WHOOP appears to be deliberately laying the groundwork for an Initial Public Offering (IPO). The company’s emphasis on subscription revenue, proprietary health data, and regulatory clearance could make it especially attractive to public market investors seeking exposure to the fast-growing preventive health and longevity sectors. 

WHOOP’s evolution may offer a blueprint for how consumer tech companies can transition into credible, medically relevant platforms, without losing their appeal to everyday users. 

Read more about WHOOP’s landmark investment raise 

Subscribe to the HIN Investment Update for key investment news, exclusive insights from the HIN’s investor network, and the latest opportunities and events. Ideal for growing healthtech companies, as well as funders and investors shaping the health innovation ecosystem.